Every Form 4 that Firefly Neuroscience, Inc. (AIFF) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow AIFF and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AIFF filings page.
Firefly Neuroscience, Inc. (AIFF) granted director Stella Vnook 84,033 deferred stock units on September 25, 2026, under its 2024 Long-Term Incentive Plan. The units vest quarterly over 12 months, and each represents a contingent right to receive one common share. Her reported deferred stock unit position following the grant was 149,962 units.
Firefly Neuroscience, Inc. director Brian M. Posner received 84,033 deferred stock units on September 25, 2026, under the company's 2024 Long-Term Incentive Plan. The units vest quarterly over a twelve-month period, and each represents a contingent right to receive one share of common stock. Posner's reported direct position following the grant was 149,962 deferred stock units.
Firefly Neuroscience, Inc. (AIFF) director Arun Swarup Menawat was granted 126,050 deferred stock units on September 25, 2026, under the company’s 2024 Long-Term Incentive Plan. The units vest quarterly over twelve months, and each represents a contingent right to receive one common share. His reported position after the grant was 216,609 deferred stock units.
FIREFLY NEUROSCIENCE, INC. director and President & COO David DeCaprio reported acquiring 44,872 shares of Common Stock, received as a grant or award at a price of $0.00 per share. After this vesting event, he directly owns 77,866 Common Stock shares.
The shares relate to restricted stock units originally granted on April 18, 2025 for 263,952 shares under the 2024 Long-Term Incentive Plan. On March 10, 2026, the Compensation Committee determined the performance conditions were met, triggering vesting of these 44,872 shares as part of that larger award.
FIREFLY NEUROSCIENCE, INC. Chief Executive Officer Gregory Lipschitz reported an equity compensation vesting rather than a market trade. On March 10, 2026, he acquired 65,988 shares of Common Stock at a price of $0.0000 per share through a grant/award.
These shares relate to restricted stock units granted on April 18, 2025 for 395,927 shares under the 2024 Long-Term Incentive Plan, after the compensation committee determined performance conditions had been met for 65,988 shares. Following this vesting, he holds 530,184 shares, including 464,196 held by Bower Four Capital Corporation and 65,988 shares held directly.